Deborah Neesham

1.4k total citations
15 papers, 281 citations indexed

About

Deborah Neesham is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Epidemiology. According to data from OpenAlex, Deborah Neesham has authored 15 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Obstetrics and Gynecology, 11 papers in Reproductive Medicine and 3 papers in Epidemiology. Recurrent topics in Deborah Neesham's work include Endometrial and Cervical Cancer Treatments (11 papers), Ovarian cancer diagnosis and treatment (10 papers) and Cervical Cancer and HPV Research (3 papers). Deborah Neesham is often cited by papers focused on Endometrial and Cervical Cancer Treatments (11 papers), Ovarian cancer diagnosis and treatment (10 papers) and Cervical Cancer and HPV Research (3 papers). Deborah Neesham collaborates with scholars based in Australia, Netherlands and United States. Deborah Neesham's co-authors include Michael Quinn, Thomas J. Cade, Bryony Simcock, Rodney J. Hicks, Alvin Milner, Orla McNally, Jan Pyman, Robert Rome, Torukiri I Ibiebele and Jonathan Carter and has published in prestigious journals such as British Journal of Cancer, BJOG An International Journal of Obstetrics & Gynaecology and Gynecologic Oncology.

In The Last Decade

Deborah Neesham

11 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Neesham Australia 7 201 153 48 45 42 15 281
Adriana Yoshida Brazil 12 219 1.1× 161 1.1× 24 0.5× 42 0.9× 107 2.5× 26 339
Martina Delle Marchette Italy 9 148 0.7× 93 0.6× 18 0.4× 29 0.6× 36 0.9× 16 230
Barnaby Rufford United Kingdom 6 171 0.9× 103 0.7× 8 0.2× 41 0.9× 52 1.2× 12 244
Mareike Bommert Germany 9 181 0.9× 115 0.8× 8 0.2× 58 1.3× 89 2.1× 20 235
Peng-Hui Wang Taiwan 10 137 0.7× 81 0.5× 13 0.3× 20 0.4× 51 1.2× 17 269
Iptissem Naoura France 10 183 0.9× 235 1.5× 9 0.2× 44 1.0× 51 1.2× 18 318
Nicole C.M. Visser Netherlands 9 150 0.7× 251 1.6× 33 0.7× 41 0.9× 10 0.2× 20 317
Takayoshi Nogawa Japan 9 92 0.5× 81 0.5× 13 0.3× 59 1.3× 58 1.4× 17 204
Haruko Iwase Japan 8 106 0.5× 75 0.5× 6 0.1× 32 0.7× 39 0.9× 21 162
J. van Nagell United States 7 286 1.4× 117 0.8× 6 0.1× 44 1.0× 59 1.4× 11 337

Countries citing papers authored by Deborah Neesham

Since Specialization
Citations

This map shows the geographic impact of Deborah Neesham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Neesham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Neesham more than expected).

Fields of papers citing papers by Deborah Neesham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Neesham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Neesham. The network helps show where Deborah Neesham may publish in the future.

Co-authorship network of co-authors of Deborah Neesham

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Neesham. A scholar is included among the top collaborators of Deborah Neesham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Neesham. Deborah Neesham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
McBain, Rosemary, et al.. (2024). Sentinel lymph node detection with indocyanine green and patent blue dye in cervical cancer: A single‐centre feasibility study. Australian and New Zealand Journal of Obstetrics and Gynaecology. 64(6). 573–579. 1 indexed citations
2.
3.
McNally, Orla, et al.. (2023). Low‐risk gestational trophoblastic neoplasia – 20 years experience of a state registry. Australian and New Zealand Journal of Obstetrics and Gynaecology. 64(3). 223–229.
4.
Cade, Thomas J., et al.. (2022). Patterns of Recurrence in Low-Risk Endometrial Cancer. Open Journal of Obstetrics and Gynecology. 12(11). 1155–1165.
5.
McNally, Orla, et al.. (2021). Prognostic value of serum HE4 level in the management of endometrial cancer: A pilot study. Australian and New Zealand Journal of Obstetrics and Gynaecology. 61(2). 284–289. 4 indexed citations
6.
7.
Playdon, Mary C., Christina M. Nagle, Torukiri I Ibiebele, et al.. (2017). Pre-diagnosis diet and survival after a diagnosis of ovarian cancer. British Journal of Cancer. 116(12). 1627–1637. 45 indexed citations
8.
Cade, Thomas J., Michael Quinn, Robert Rome, & Deborah Neesham. (2013). Long‐term outcomes after progestogen treatment for early endometrial cancer. Australian and New Zealand Journal of Obstetrics and Gynaecology. 53(6). 566–570. 13 indexed citations
9.
Cade, Thomas J., et al.. (2010). Predictive Value of Magnetic Resonance Imaging in Assessing Myometrial Invasion in Endometrial Cancer. International Journal of Gynecological Cancer. 20(7). 1166–1169. 27 indexed citations
10.
Cade, Thomas J., et al.. (2010). Progestogen treatment options for early endometrial cancer. BJOG An International Journal of Obstetrics & Gynaecology. 117(7). 879–884. 51 indexed citations
11.
Zusterzeel, Petra L.M., Ruud L.M. Bekkers, Jan C.M. Hendriks, et al.. (2008). Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer. Acta Obstetricia Et Gynecologica Scandinavica. 87(2). 240–246. 13 indexed citations
12.
Zusterzeel, Petra L.M., Ruud L.M. Bekkers, Jan C.M. Hendriks, et al.. (2008). Prognostic Factors for Recurrence in Patients With FIGO Stage I and II Intermediate or High Risk Endometrial Cancer. Obstetrical & Gynecological Survey. 63(6). 369–370.
13.
Neesham, Deborah. (2007). Ovarian cancer screening.. PubMed. 36(3). 126–8. 31 indexed citations
14.
Simcock, Bryony, et al.. (2006). The impact of PET/CT in the management of recurrent ovarian cancer. Gynecologic Oncology. 103(1). 271–276. 93 indexed citations
15.
Bardsley, Michael R., et al.. (2004). Benign endocervical cystic glandular change mimicking minimal deviation adenocarcinoma of the cervix on magnetic resonance imaging: A case report. Australian and New Zealand Journal of Obstetrics and Gynaecology. 44(4). 358–359. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adriana Yoshida Breakdown of academic impact, for papers by Martina Delle Marchette Breakdown of academic impact, for papers by Barnaby Rufford Breakdown of academic impact, for papers by Mareike Bommert Breakdown of academic impact, for papers by Peng-Hui Wang Breakdown of academic impact, for papers by Iptissem Naoura Breakdown of academic impact, for papers by Nicole C.M. Visser Breakdown of academic impact, for papers by Takayoshi Nogawa Breakdown of academic impact, for papers by Haruko Iwase Breakdown of academic impact, for papers by J. van Nagell
Rankless by CCL
2026